Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease... see more

TSX:SZLS - Post Discussion

StageZero Life Sciences Ltd > Aristotle Test now $949 USD
View:
Post by Tylerdude on Oct 04, 2022 4:43pm

Aristotle Test now $949 USD

Recieved a email from Stage Zero this morning.

Aristotle is now $949 USD with testing available in  Toronto Ontario, Van Nuys California, Gairthersubrg Maryland, Vernon Hills Illinois, Branchburg New Jersey, Coppell Texas and Richmon Virginia.

https://www.stagezerolifesciences.com/aristotle-enrollment.html


https://app.acuityscheduling.com/schedule.php?owner=20161544&appointmentType=28616162
Comment by Liked2Think on Oct 04, 2022 5:00pm
Pumper patrol will label this as a "great decision as its more affordable and will therefore mean more tests" Bashers will label this as "so they cant sell any tests and they think lowering the price will magically fix that" What camp do you sit in? One question though. If they were selling tests at the previous cost why would they lower them in this day of age of high ...more  
Comment by LithLover on Oct 04, 2022 5:39pm
The Care Oncology piece is now pretty much cash flow positive.  They had under $100k in cash at the end of June and only raised 170k for the quarter.  Given the company is nearly 100% supportive by Care Oncology looks like a renewed focus on Aristotle and the overall revenue for the company. If they can make money on Aristotle (even at a lower amount) but it drives patients into the ...more  
Comment by Liked2Think on Oct 04, 2022 6:27pm
I agree with your assesment but I do not view it as a great sign because of the following. 1. Stage has previous cancer tests that made them no money. 2. Covid was "lucky" for Stagezero even though that is crazy to say.  Only way they have made money to date. 3. Stage used Covid money and their covid money SP at the time to buy another company that was much more successfull as ...more  
Comment by 4real4ever on Oct 05, 2022 8:59am
This post has been removed in accordance with Community Policy
Comment by Nailbiter2 on Oct 04, 2022 7:08pm
This post has been removed in accordance with Community Policy
Comment by Nailbiter2 on Oct 04, 2022 7:16pm
This post has been removed in accordance with Community Policy
Comment by Nailbiter2 on Oct 04, 2022 8:06pm
This post has been removed in accordance with Community Policy
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities